CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 1,459 shares at $18.61 ($27,152)
- 4 Open-market sale See remarks sold 748 shares at $18.61 ($13,920)
- 4 Open-market sale President, R&D sold 2,237 shares at $18.61 ($41,631)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President, R&D sold 8,660 shares at $18.71 ($162,029)
- 4 Planned sale President and CEO sold 48,199 shares at $19.58 ($943,736)
- 4 Planned sale Chief Financial Officer sold 17,717 shares at $18.69 ($331,131)
- 144 Insider Sale of Securities
- 4 Planned sale See remarks sold 50,000 shares at $19.09 ($954,500)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 187,163 shares at an average $16.97 ($3,176,865)
- 4 Planned sale President, R&D sold 93,456 shares at $16.94 ($1,583,145)
Page 2 of 28 · 556 filings